EPM editor Reece Armstrong sits down with Andrew Bulpin - head of process solutions at the life science business of Merck - to discuss the industry and the company’s new platform for ‘contiGuous’ manufacturing in bioprocessing.
Dr Niklas Sandler, chief technology officer at Nanoform, explains why the use of nanonisation and artificial intelligence (AI) can help pharmaceutical manufacturers unlock added value for bioavailable nanoparticles.
Chris Whitehead, managed platform product manager at SolutionsPT, looks at the importance of disaster resilience and the solutions available to help protect pharmaceutical manufacturers from the loss of critical data and interruptions to production.
European Pharmaceutical Manufacturer editor Reece Armstrong sits down with Neil Gleghorn, CEO of labelling provider Kallik, to discuss compliance challenges for manufacturers and the threat of counterfeit medicines.
In the wake of the Theranos disaster, Dave Edwards, executive vice president of sales at MasterControl, explains why digital transformation is key if pharma companies are to achieve transparency throughout product development.
In this article, Scott McDougall, co-founder and registered manager of The Independent Pharmacy outlines five technological advancements that are taking the fight to fake drugs.
In this article, John Norman, mechanical drafter and designer for Technical Service Support at Natoli Engineering, breaks the misconceptions of maximum compression force.
In this whitepaper, Christoph Krähenbühl, senior director of Excellis Europe, explains the challenge new Russian traceability regulations present to the pharma industry.
